Literature DB >> 10400956

Role of metabotropic glutamate receptor subtype mGluR1 in brief nociception and central sensitization of primate STT cells.

V Neugebauer1, P S Chen, W D Willis.   

Abstract

G-protein coupled metabotropic glutamate receptors (mGluRs) are important modulators of synaptic transmission in the mammalian CNS and have been implicated in various forms of neuroplasticity and nervous system disorders. Increasing evidence also suggests an involvement of mGluRs in nociception and pain behavior although the contribution of individual mGluR subtypes is not yet clear. Subtypes mGluR1 and mGluR5 are classified as group I mGluRs and share the ability to stimulate phosphoinositide hydrolysis and activate protein kinase C. The present study examined the role of group I mGluRs in nociceptive processing and capsaicin-induced central sensitization of primate spinothalamic tract (STT) cells in vivo. In 10 anesthetized male monkeys (Macaca fascicularis) extracellular recordings were made from 20 STT cells in the lumbar dorsal horn. Responses to brief (15 s) cutaneous stimuli of innocuous (BRUSH) and barely and substantially noxious (PRESS and PINCH, respectively) intensity were recorded before, during, and after the infusion of group I mGluR agonists and antagonists into the dorsal horn by microdialysis. Cumulative concentration-response relationships were obtained by applying different concentrations for at least 20 min each (at 5 microl/min). The actual concentrations reached in the tissue are 2-3 orders of magnitude lower than those in the microdialysis fibers (values in this paper refer to the latter). The group I antagonists were also applied at 10-25 min after capsaicin injection. S-DHPG, a group I agonist at both mGluR1 and mGluR5, potentiated the responses to innocuous and noxious stimuli (BRUSH > PRESS > PINCH) at low concentrations (10-100 microM; n = 5) but had inhibitory effects at higher concentrations (1-10 mM; n = 5). The mGluR5 agonist CHPG (1 microM-100 mM; n = 5) did not potentiate but inhibited all responses (10-100 mM; n = 5). AIDA (1 microM-100 mM), a mGluR1-selective antagonist, dose-dependently depressed the responses to PINCH and PRESS but not to BRUSH (n = 6). The group I (mGluR1 > mGluR5) antagonist CPCCOEt (1 microM-100 mM) had similar effects (n = 6). Intradermal injections of capsaicin sensitized the STT cells to cutaneous mechanical stimuli. The enhancement of the responses by capsaicin resembled the potentiation by the group I mGluR agonist S-DHPG (BRUSH > PRESS > PINCH). CPCCOEt (1 mM) reversed the capsaicin-induced sensitization when given as posttreatment (n = 5). After washout of CPCCOEt, the sensitization resumed. Similarly, AIDA (1 mM; n = 7) reversed the capsaicin-induced sensitization and also blocked the potentiation by S-DHPG (n = 5). These data suggest that the mGluR1 subtype is activated endogenously during brief high-intensity cutaneous stimuli (PRESS, PINCH) and is critically involved in capsaicin-induced central sensitization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400956     DOI: 10.1152/jn.1999.82.1.272

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  27 in total

1.  Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice.

Authors:  F Karim; C C Wang; R W Gereau
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  Involvement of metabotropic glutamate receptor 5 in pudendal inhibition of nociceptive bladder activity in cats.

Authors:  Jeffrey A Larson; P Dafe Ogagan; Guoqing Chen; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai
Journal:  J Physiol       Date:  2011-10-17       Impact factor: 5.182

3.  Metabotropic glutamate and cannabinoid receptor crosstalk in periaqueductal grey pain processing.

Authors:  E Palazzos; V de Novellis; I Marabese; F Rossi; S Maione
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

4.  Chapter 9 The dorsal horn and hyperalgesia.

Authors:  Karin N Westlund
Journal:  Handb Clin Neurol       Date:  2006

5.  Enhanced phosphorylation of NMDA receptor 1 subunits in spinal cord dorsal horn and spinothalamic tract neurons after intradermal injection of capsaicin in rats.

Authors:  X Zou; Q Lin; W D Willis
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

6.  Knockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in rats.

Authors:  M E Fundytus; K Yashpal; J G Chabot; M G Osborne; C D Lefebvre; A Dray; J L Henry; T J Coderre
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

7.  Cognitive impairment in pain through amygdala-driven prefrontal cortical deactivation.

Authors:  Guangchen Ji; Hao Sun; Yu Fu; Zhen Li; Miguel Pais-Vieira; Vasco Galhardo; Volker Neugebauer
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

8.  Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization.

Authors:  Alejandro J Pernía-Andrade; Ako Kato; Robert Witschi; Rita Nyilas; István Katona; Tamás F Freund; Masahiko Watanabe; Jörg Filitz; Wolfgang Koppert; Jürgen Schüttler; Guangchen Ji; Volker Neugebauer; Giovanni Marsicano; Beat Lutz; Horacio Vanegas; Hanns Ulrich Zeilhofer
Journal:  Science       Date:  2009-08-07       Impact factor: 47.728

9.  Group I metabotropic glutamate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrosine phosphorylation associated with inflammatory hyperalgesia.

Authors:  Wei Guo; Feng Wei; Shiping Zou; Meredith T Robbins; Shinichi Sugiyo; Tetsuya Ikeda; Jian-Cheng Tu; Paul F Worley; Ronald Dubner; Ke Ren
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

10.  Regulation of increased glutamatergic input to spinal dorsal horn neurons by mGluR5 in diabetic neuropathic pain.

Authors:  Ji-Qing Li; Shao-Rui Chen; Hong Chen; You-Qing Cai; Hui-Lin Pan
Journal:  J Neurochem       Date:  2009-10-15       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.